Evidence map›Paper›PMID 38411377›Full record

SynthesisImmunity, inflammation and disease2024

Prevalence of latent tuberculosis infection in Asian nations: A systematic review and meta-analysis.

Abhigan B Shrestha, Imran S Siam, Jarin Tasnim, Abhinav Dahal, Poulami Roy, Sushil Neupane, Ashok Adhikari, Barsha Khanal, Rupesh Ghimirie, Dikshya Shrestha and 5 more

Open access · goldAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Immunity, inflammation and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 4 countries.

Abhigan B ShresthaDepartment of Internal Medicine, M Abdur Rahim Medical College, Dinajpur, Bangladesh.ORCID http://orcid.org/0000-0002-0681-3825
Imran S SiamDepartment of Internal Medicine, Chattagram Maa O Shishu Medical College, Chattogram, Bangladesh.
Jarin TasnimDepartment of Internal Medicine, Chattagram Maa O Shishu Medical College, Chattogram, Bangladesh.
Abhinav DahalDepartment of Internal Medicine, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal.
Poulami RoyNorth Bengal Medical College and Hospital, Siliguri, West Bengal, India.
Sushil NeupaneDepartment of Internal Medicine, Manipal College of Medical Sciences, Pokhara, Nepal.
Ashok AdhikariDepartment of Internal Medicine, Universal College of Medical Sciences, Bhairawa, Nepal.
Barsha KhanalDepartment of Internal Medicine, Rangpur Medical College, Rangpur, Bangladesh.
Rupesh GhimirieDepartment of Internal Medicine, Kist Medical College and Teaching Hospital, Patan, Nepal.ORCID http://orcid.org/0009-0002-0471-7626
Dikshya ShresthaDepartment of Internal Medicine, Kist Medical College and Teaching Hospital, Patan, Nepal.
Suju BhattaraiDepartment of Internal Medicine, Kathmandu Medical College and Teaching Hospital, Kathmandu, Nepal.
Sajina ShresthaDepartment of Internal Medicine, Kist Medical College and Teaching Hospital, Patan, Nepal.
Nischal MainaliKathmandu Medical College and Teaching Hospital, Kathmandu, Nepal.
Yub Raj SedhaiDivision of Pulmonary Disease and Critical Care Medicine, University of Kentucky College of Medicine, Bowling Green, Kentucky, USA.
Uday SinghDepartment of Internal Medicine, Nobel Medical College, Biratnagar, Nepal.
KIST Medical College · NPChattagram Maa-O-Shishu Hospital Medical College · BDDinajpur Medical College · BDKathmandu Medical College Teaching Hospital · NPBiratnagar Eye Hospital · NPCollege of Medical Sciences · NPManipal College of Medical Sciences · NPNepalese Army Institute of Health Services · NPNorth Bengal Medical College and Hospital · INUniversity of Kentucky · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) is a serious public health concern around the world including Asia. TB burden is high in Asian countries and significant population harbor latent tuberculosis infection(LTBI).

aimThis systematic review and meta-analysis aims to evaluate the prevalence of LTBI in Asian countries.

methodWe performed a systematic literature search on PubMed, Embase, and ScienceDirect to identify relevant articles published between January 1, 2005, and January 1, 2023 investigating the overall prevalence of latent TB among people of Asia. Subgroup analysis was done for Asian subregions during the study period of 2011 to 2016 and 2017 to 2023, for tuberculin skin test (TST) and interferon gamma release assay (IGRA), respectively, as well as for QuantiFERON-TB (QFT) and TSPOT TB tests. Der Simonian and Laird's random-effects model was used to pool the prevalence of LTBI found using TST and IGRA.

resultA total of 15 studies were included after a systematic search from standard electronic databases. The analysis showed that the prevalence of latent TB in Asia was 21% (95% confidence interval [CI]: 19%-23%) and 36% (95% CI: 12%-59%) according to IGRAs and TSTs (cut off 10 mm) results, respectively. Based on IGRA, the prevalence of latent TB was 20% (95% CI: 13%-25%) in 2011 to 2016 and 21% (95% CI: 18%-24%) in 2017 to 2023. Using QFT, the prevalence was 19% (95% CI: 17%-22%) and using TSPOT, the prevalence was 26% (95% CI: 21%-31%). According to the United Nations division of Asia, the prevalence was higher for the Southern region and least for the Western region using TST and higher in the South-Eastern region and least in the Western region using the IGRA test.

conclusionAlmost a quarter of the Asian population has LTBI. Its diagnosis often poses a diagnostic challenge due to the unavailability of standard test in certain areas. Given this prevalence, a mass screening program is suggested with the available standard test and public awareness along with anti-TB regimen should be considered for individuals who test positive. However, for it to be implemented effectively, we need to take the affordability, availability, and cost-effectiveness of such interventions into account.

Indexed as

Latent TuberculosisBiological AssayDatabases, FactualHumansPrevalenceAsianIGRAlatent tuberculosisTSTtuberculosis

Identifiers

PMID38411377
PMCPMC10898208
OpenAlexW4392202998

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.